Radiation injury to cardiac arteries and myocardium is reduced by soy isoflavones
ConclusionOur histopathological findings suggest a radioprotective role of soy isoflavones to prevent cardiac injury. This approach could translate to the use of soy isoflavones as a safe complement to thoracic radiotherapy with the goal of improving the overall survival in patients whose cancer has been successfully controlled by the radiotherapy but who otherwise succumb to heart toxicity.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Congestive Heart Failure | Esophagus Cancer | Heart | Heart Attack | Heart Failure | Lung Cancer | Lymphoma | Non-Small Cell Lung Cancer | Oral Cancer | Soy | Soy isoflavones | Study | Toxicology